- Home
- SRTS vs BRNS Comparison
SRTS vs BRNS Comparison
Compare SRTS & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- BRNS
- Stock Information
- Founded
- SRTS 2010
- BRNS 2016
- Country
- SRTS United States
- BRNS United Kingdom
- Employees
- SRTS N/A
- BRNS N/A
- Industry
- SRTS Medical/Dental Instruments
- BRNS Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- BRNS Health Care
- Exchange
- SRTS Nasdaq
- BRNS Nasdaq
- Market Cap
- SRTS 51.8M
- BRNS 48.3M
- IPO Year
- SRTS 2016
- BRNS 2021
- Fundamental
- Price
- SRTS $3.15
- BRNS $1.11
- Analyst Decision
- SRTS Strong Buy
- BRNS Strong Buy
- Analyst Count
- SRTS 3
- BRNS 1
- Target Price
- SRTS $8.00
- BRNS $3.00
- AVG Volume (30 Days)
- SRTS 84.7K
- BRNS 44.4K
- Earning Date
- SRTS 11-13-2025
- BRNS 11-05-2025
- Dividend Yield
- SRTS N/A
- BRNS N/A
- EPS Growth
- SRTS N/A
- BRNS N/A
- EPS
- SRTS N/A
- BRNS N/A
- Revenue
- SRTS $37,564,000.00
- BRNS $14,969,000.00
- Revenue This Year
- SRTS N/A
- BRNS N/A
- Revenue Next Year
- SRTS $46.14
- BRNS N/A
- P/E Ratio
- SRTS N/A
- BRNS N/A
- Revenue Growth
- SRTS 3.29
- BRNS 1766.46
- 52 Week Low
- SRTS $3.03
- BRNS $0.64
- 52 Week High
- SRTS $9.33
- BRNS $2.92
- Technical
- Relative Strength Index (RSI)
- SRTS 37.43
- BRNS 44.73
- Support Level
- SRTS $3.09
- BRNS $0.99
- Resistance Level
- SRTS $3.29
- BRNS $1.20
- Average True Range (ATR)
- SRTS 0.11
- BRNS 0.08
- MACD
- SRTS 0.04
- BRNS -0.01
- Stochastic Oscillator
- SRTS 15.38
- BRNS 31.94
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.